CEO changes
Chief executive officer appointments and departures from SEC 8-K filings.
Updated Nov 6, 2026
CEO changes, last 12 months
380
Appointments
210
Departures
27
Other roles
Get new CEO changes by email
Appointments and departures per month
December 2025 to November 2026
| Month | Appointments | Departures |
|---|---|---|
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 59 | 12 |
| September 2026 | 67 | 6 |
| October 2026 | 59 | 4 |
| November 2026 | 25 | 5 |
Sectors with the most CEO changes
Last 12 months
| Sector | CEO changes |
|---|---|
| Software | 24 |
| Biotechnology | 12 |
| Energy | 7 |
| Professional services | 6 |
| Banking and finance | 5 |
| Electronics | 4 |
| Insurance | 3 |
| Restaurants | 3 |
| Health care | 1 |
Filters
380 changes
| Filing date | Company | Person | Change | Effective date | Source |
|---|---|---|---|---|---|
| Oct 28, 2026 | LENZ Therapeutics, Inc. | Evert Schimmelpennink | Departed | Dec 1, 2026 | SEC 8-K |
| Oct 28, 2026 | LENZ Therapeutics, Inc. | Daniel Chevallard | Appointed | Dec 1, 2026 | SEC 8-K |
| Oct 28, 2026 | LENZ Therapeutics, Inc. | Daniel Chevallard | Appointed | Dec 1, 2026 | SEC 8-K |
| Oct 28, 2026 | Monroe Federal Bancorp, Inc. | Lewis R. Renollet | Departed | Oct 26, 2026 | SEC 8-K |
| Oct 28, 2026 | Monroe Federal Bancorp, Inc. | Charles G. Brown III | Appointed | Oct 26, 2026 | SEC 8-K |
| Oct 28, 2026 | Q2 Holdings, Inc. | Jonathan A. Price | Appointed | Oct 29, 2026 | SEC 8-K |
| Oct 29, 2026 | CLOROX CO /DE/ | Fabian Garcia | Appointed | Jan 5, 2027 | SEC 8-K |
| Oct 29, 2026 | CLOROX CO /DE/ | Linda Rendle | Departed | Jan 5, 2027 | SEC 8-K |
| Oct 29, 2026 | Estrella Immunopharma, Inc. | Cynthia Pussinen | Appointed | Oct 25, 2026 | SEC 8-K |
| Oct 29, 2026 | Shutterstock, Inc. | Jonathan Oringer | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 30, 2026 | American Fusion, Inc. | Richard C. Hawkins | Departed | Oct 26, 2026 | SEC 8-K |
| Oct 30, 2026 | American Fusion, Inc. | Brent Nelson | Appointed | Oct 26, 2026 | SEC 8-K |
| Oct 30, 2026 | BioXcel Therapeutics, Inc. | Vimal Mehta, Ph.D. | Departed | Oct 31, 2026 | SEC 8-K |
| Oct 30, 2026 | EQUITY LIFESTYLE PROPERTIES INC | Patrick Waite | Appointed | Jan 1, 2027 | SEC 8-K |
| Oct 30, 2026 | GENWORTH FINANCIAL INC | Jerome T. Upton | Appointed | Jan 1, 2027 | SEC 8-K |
| Oct 30, 2026 | Zoned Properties, Inc. | Bryan McLaren | Departed | Oct 30, 2026 | SEC 8-K |
| Nov 2, 2026 | AbbVie Inc. | Jennifer L. Davis | Appointed | n/a | SEC 8-K |
| Nov 2, 2026 | CBIZ, Inc. | Jim Peko | Appointed | Nov 2, 2026 | SEC 8-K |
| Nov 2, 2026 | Chord Energy Corp | Michael Lou | Appointed | Oct 19, 2026 | SEC 8-K |
| Nov 2, 2026 | Commercial Vehicle Group, Inc. | David Ruppel | Appointed | Nov 9, 2026 | SEC 8-K |
Sort:Filing date ↑Company
- LENZ Therapeutics, Inc.Departed
Evert Schimmelpennink CEO
Filed Oct 28, 2026Effective Dec 1, 2026SEC 8-K
- LENZ Therapeutics, Inc.Appointed
Daniel Chevallard CEO
Filed Oct 28, 2026Effective Dec 1, 2026SEC 8-K
- LENZ Therapeutics, Inc.Appointed
Daniel Chevallard CEO
Filed Oct 28, 2026Effective Dec 1, 2026SEC 8-K
- Monroe Federal Bancorp, Inc.Departed
Lewis R. Renollet CEO
Filed Oct 28, 2026Effective Oct 26, 2026SEC 8-K
- Monroe Federal Bancorp, Inc.Appointed
Charles G. Brown III CEO
Filed Oct 28, 2026Effective Oct 26, 2026SEC 8-K
- Q2 Holdings, Inc.Appointed
Jonathan A. Price CEO
Filed Oct 28, 2026Effective Oct 29, 2026SEC 8-K
- CLOROX CO /DE/Appointed
Fabian Garcia CEO
Filed Oct 29, 2026Effective Jan 5, 2027SEC 8-K
- CLOROX CO /DE/Departed
Linda Rendle CEO
Filed Oct 29, 2026Effective Jan 5, 2027SEC 8-K
- Estrella Immunopharma, Inc.Appointed
Cynthia Pussinen CEO
Filed Oct 29, 2026Effective Oct 25, 2026SEC 8-K
- Shutterstock, Inc.Appointed
Jonathan Oringer CEO
Filed Oct 29, 2026Effective Oct 28, 2026SEC 8-K
- American Fusion, Inc.Departed
Richard C. Hawkins CEO
Filed Oct 30, 2026Effective Oct 26, 2026SEC 8-K
- American Fusion, Inc.Appointed
Brent Nelson CEO
Filed Oct 30, 2026Effective Oct 26, 2026SEC 8-K
- BioXcel Therapeutics, Inc.Departed
Vimal Mehta, Ph.D. CEO
Filed Oct 30, 2026Effective Oct 31, 2026SEC 8-K
- EQUITY LIFESTYLE PROPERTIES INCAppointed
Patrick Waite CEO
Filed Oct 30, 2026Effective Jan 1, 2027SEC 8-K
- GENWORTH FINANCIAL INCAppointed
Jerome T. Upton CEO
Filed Oct 30, 2026Effective Jan 1, 2027SEC 8-K
- Zoned Properties, Inc.Departed
Bryan McLaren CEO
Filed Oct 30, 2026Effective Oct 30, 2026SEC 8-K
- AbbVie Inc.Appointed
Jennifer L. Davis CEO
Filed Nov 2, 2026SEC 8-K
- CBIZ, Inc.Appointed
Jim Peko CEO
Filed Nov 2, 2026Effective Nov 2, 2026SEC 8-K
- Chord Energy CorpAppointed
Michael Lou CEO
Filed Nov 2, 2026Effective Oct 19, 2026SEC 8-K
- Commercial Vehicle Group, Inc.Appointed
David Ruppel CEO
Filed Nov 2, 2026Effective Nov 9, 2026SEC 8-K